title: Modeling single and repeated dose pharmacokinetics of PFOA in mice.
abstract: Perfluorooctanoic acid (PFOA) displays complicated pharmacokinetics in that serum concentrations indicate long half-lives despite which steady state appears to be achieved rapidly. In this study, serum and tissue concentration time-courses were obtained for male and female CD1 mice after single, oral doses of 1 and 10 mg/kg of PFOA. When using one- and two-compartment models, the pharmacokinetics for these two dosages are not consistent with serum time-course data from female CD1 mice administered 60 mg/kg, or with serum concentrations following repeated daily doses of 20 mg/kg PFOA. Some consistency between dose regimens could be achieved using the saturable resorption model of Andersen et al. In this model PFOA is cleared from the serum into a filtrate compartment from which it is either excreted or resorbed into the serum by a process presumed transporter mediated with a Michaelis-Menten form. Maximum likelihood estimation found a transport maximum of T(m) = 860.9 (1298.3) mg/l/h and half-maximum concentration of K(T) = 0.0015 (0.0022) mg/l where the estimated standard errors (in parentheses) indicated large uncertainty. The estimated rate of flow into and out of the filtrate compartment, 0.6830 (1.0131) l/h was too large to be consistent with a biological interpretation. For these model parameters a single dose greater than 40 mg/kg, or a daily dose in excess of 5 mg/kg were necessary to observe nonlinear pharmacokinetics for PFOA in female CD1 mice. These data and modeling analyses more fully characterize PFOA in mice for purposes of estimating internal exposure for use in risk assessment.
authors.affiliation: National Center for Computational Toxicology, US Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.
authors.forename: Inchio
authors.initials: I
authors.lastname: Lou
authors.forename: John F
authors.initials: JF
authors.lastname: Wambaugh
authors.forename: Christopher
authors.initials: C
authors.lastname: Lau
authors.forename: Roger G
authors.initials: RG
authors.lastname: Hanson
authors.forename: Andrew B
authors.initials: AB
authors.lastname: Lindstrom
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Strynar
authors.forename: R Dan
authors.initials: RD
authors.lastname: Zehr
authors.forename: R Woodrow
authors.initials: RW
authors.lastname: Setzer
authors.forename: Hugh A
authors.initials: HA
authors.lastname: Barton
mesh_terms: D000465:Algorithms; D000818:Animals; D002210:Caprylates / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D006207:Half-Life; D016013:Likelihood Functions; D008297:Male; D051379:Mice; D015233:Models, Statistical; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012727:Sex Characteristics; D014018:Tissue Distribution
chemical_list: D002210:Caprylates; D005466:Fluorocarbons; C023036:perfluorooctanoic acid